In addition, vinorelbine, cyclophosphamide, and 5-FU had significant preclinical effects on circulating and tumour-infiltrating immune cells and could be used to obtain synergy with anti-PD-L1 [60]. The gene discussed is CD274; the disease is neoplasm.